Cancer testis antigen vaccination affords long-term protection in a murine model of ovarian cancer.
Sperm protein (Sp17) is an attractive target for ovarian cancer (OC) vaccines because of its over-expression in primary as well as in metastatic lesions, at all stages of the disease. Our studies suggest that a Sp17-based vaccine can induce an enduring defense against OC development in C57BL/6 mice...
Main Authors: | Maurizio Chiriva-Internati, Yuefei Yu, Leonardo Mirandola, Marjorie R Jenkins, Caroline Chapman, Martin Cannon, Everardo Cobos, W Martin Kast |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2868870?pdf=render |
Similar Items
-
Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma
by: Frezza Eldo E, et al.
Published: (2007-01-01) -
Aging, cancer, and cancer vaccines
by: Mazzola Paolo, et al.
Published: (2012-04-01) -
Galectin-3C inhibits tumor growth and increases the anticancer activity of bortezomib in a murine model of human multiple myeloma.
by: Leonardo Mirandola, et al.
Published: (2011-01-01) -
Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4
by: Jenkins Marjorie R, et al.
Published: (2011-09-01) -
Cancer immunotherapy: avoiding the road to perdition
by: Bright Robert K, et al.
Published: (2004-07-01)